Mark Sandbaken
Profile
Dr. Mark Sandbaken is Vice President-Intellectual Property at Seattle Genetics, Inc.
He received his undergraduate degree from Carleton College, a graduate degree from the S.J.
Quinney College of Law, and a doctorate degree from the University of Wisconsin.
Former positions of Mark Sandbaken
| Companies | Position | End |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | - |
Training of Mark Sandbaken
| University of Wisconsin | Doctorate Degree |
| Carleton College | Undergraduate Degree |
| S.J. Quinney College of Law | Graduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- Mark Sandbaken
